A closer look at the Parexel deal
Another day, another CRO acquisition – this time Parexel, a top 10 CRO, was acquired by Pamplona Capital, a large private equity firm.
Archives for June 20, 2017
DIA 2017
Deloitte to upgrade Daiichi Sankyo's global drug safety platform
Daiichi Sankyo has adopted Deloitte’s ConvergeHEALTH Safety platform in order to enhance its global pharmacovigilance capabilities.
Germany’s Merck invests in immune-oncology in Switzerland
Merck KGaA’s corporate venture division has created an immune-oncology company based on a mixture of small and large molecule drugs, including Merck and Pfizer’s Bavencio (avelumab).
US bans drugs and all but one API made at three IPCA Labs plants
The US FDA has banned all drugs and all but one of the APIs made by Ipca Laboratories at its facilities in Ratlam, Indore and Piparia.
Implementing continuous manufacturing a challenge, say industry delegates
Industry professionals at a continuous manufacturing (CM) summit last month said while the approach offers advantages, implementing the method can be challenging.
Corning life science focus: '21st century glass for 21st century drugs'
Corning says it is on the brink of capturing an increased share of the $12bn glass quality and packaging markets through material advancements in the space.
Patient deaths end Seattle Genetics leukaemia Phase III trial
Seattle Genetics announced it has discontinued its Phase III Cascade trial of Vadastuximab Talirine (SGN-CD33A) for the treatment of frontline acute myeloid leukaemia (AML), due to patient deaths.